Company Filing History:
Years Active: 2012-2013
Title: The Innovations of Joachim Vogt
Introduction
Joachim Vogt is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of 2 patents, his work focuses on compounds that have the potential to treat various diseases, including cancer.
Latest Patents
Vogt's latest patents include innovative compounds such as Pyrido [2,3-D] pyrimidines and their use as kinase inhibitors. This invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one, which are recognized for their anti-proliferative activity against tumor cells. These compounds are particularly useful in the treatment of diseases, including cancer. Another significant patent involves Raf inhibitors, which also provide derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds serve as inhibitors of kinases such as Raf and demonstrate similar anti-proliferative properties.
Career Highlights
Joachim Vogt is currently associated with Forma Therapeutics, Inc., where he continues to advance his research in the field of kinase inhibitors. His work is pivotal in the ongoing fight against cancer and other proliferative diseases.
Collaborations
Throughout his career, Vogt has collaborated with esteemed colleagues, including Rebecca L Casaubon and Arthur F Kluge. These collaborations have further enriched his research and contributed to the development of innovative therapeutic solutions.
Conclusion
Joachim Vogt's contributions to the field of medicinal chemistry, particularly through his patents on kinase inhibitors, highlight his role as a significant inventor. His work continues to pave the way for advancements in cancer treatment and other related diseases.